Teladoc stock is set for a big comeback, says Goldman Sachs.
Teladoc (ticker: TDOC) stock was battered in 2021. Though memberships boomed as the pandemic unfolded in 2020, sending the stock up nearly 139% that year, such gains created a high bar that Teladoc struggled to clear the following year.
Similarly Will teladoc ever make money? Teladoc has never turned a profit — at least not using generally accepted accounting principles (GAAP). Yet hypergrowth fueled by the pandemic and a few acquisitions have pushed revenue up nearly three-fold since the end of 2019.
Why has Teladoc stock gone down? The stock price of Teladoc (NASDAQ:TDOC), a telemedicine and virtual healthcare company, has seen a fall of 20% over the last month, while it is down more than 70% over the last one year. The market is trying to look beyond Covid-19, as therapeutic options for Covid-19 improve and as the virus potentially gets milder.
Additionally, Is teladoc a good company?
The employee experience below at Teladoc Health (formerly Livongo), compared to a typical company. 84% of employees at Teladoc Health (formerly Livongo) say it is a great place to work compared to 57% of employees at a typical U.S.-based company. Source: Great Place to Work® 2021 Global Employee Engagement Study.
How much cash does Teladoc have?
Compare TDOC With Other Stocks
| Teladoc Health Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $787 |
| 2019 | $517 |
| 2018 | $479 |
| 2017 | $122 |
Is Teladoc a good company? The employee experience below at Teladoc Health (formerly Livongo), compared to a typical company. 84% of employees at Teladoc Health (formerly Livongo) say it is a great place to work compared to 57% of employees at a typical U.S.-based company. Source: Great Place to Work® 2021 Global Employee Engagement Study.
Why is Teladoc stock going down? The stock price of Teladoc (NASDAQ:TDOC), a telemedicine and virtual healthcare company, has seen a fall of 20% over the last month, while it is down more than 70% over the last one year. The market is trying to look beyond Covid-19, as therapeutic options for Covid-19 improve and as the virus potentially gets milder.
Who owns Teladoc? Teladoc Health
| Formerly | Teladoc Medical Services Teladoc, Inc. |
|---|---|
| Founders | Byron Brooks Michael Gorton |
| Headquarters | Purchase, New York, U.S. |
| Areas served | 130+ countries |
| Key people | Jason Gorevic (CEO) Mala Murthy (CFO) David Sides (COO) |
Who are Teladoc competitors?
Teladoc Health’s top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.
Where is Teladoc based? Teladoc Health
| Formerly | Teladoc Medical Services Teladoc, Inc. |
|---|---|
| Industry | Medical care |
| Founded | 2002 in Dallas, Texas, U.S. |
| Founders | Byron Brooks Michael Gorton |
| Headquarters | Purchase, New York, U.S. |
Is Teladoc Health legit?
Both Teladoc and Amwell are large telehealth companies that offer medical and mental health care from licensed therapists, board-certified doctors, and psychiatrists.
How does teladoc make money? How does Teladoc Make Money? Teladoc’s major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.
Who are teladoc competitors?
Teladoc Health’s top competitors include naviHealth, Lash Group, Amwell, 98point6, MDLIVE, Providence Service Corporation and Sharecare. Teladoc Health is a telehealth company that uses telephone and video conferencing technology to provide on-demand remote medical care via mobile devices, the internet, and video.
Is Teladoc a good stock to buy 2021?
Continued strong growth
In the third quarter of 2021, Teladoc reported year-over-year revenue growth of 81%, continuing a streak of sequential revenue growth since the beginning of 2019. On its own, the 81% revenue growth is excellent, but it’s even more impressive considering that Q3 of 2020 featured growth of 108%.
Is Doc stock a good buy? CloudMD(DOC-X) Rating
A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
How many customers does Teladoc have? Teladoc ended the quarter with U.S. paid membership of 51.5 million members, an increase of 20% over the prior-year quarter.
Where is Teladoc based?
Teladoc is a telehealth provider based in Purchase, N.Y.
How does Teladoc make money? How does Teladoc Make Money? Teladoc’s major revenue source is from the subscription-based model. Patients pay annual or monthly fees for consultation. The subscription-based plan starts from $49, they also sell services to clients on behalf of their employees.
Who is Teladoc biggest competitor?
1. Amwell. Amwell (NYSE: AMWL) formerly known as American Well, is a telemedicine company founded in 2006 and went public in 2020. It is currently the biggest competitor to Teladoc in the telehealth space and has experienced significant growth in recent times.
Who is using Teladoc? Customers include more than 40% of Fortune 500 employers, 50 top payers and more than 450 hospitals and health systems, including giants like UnitedHealth, CVS and academic medical center Johns Hopkins.
